At Onorach we understand the clinical development challenges in endocrinology and can work with you to ensure your plan is strategic, efficient and effective in these areas:
  • Diabetes
  • Obesity
  • Calcium disorders (Osteoporosis)
  • Growth hormone disorders (including acromegaly)
  • Pituitary hormone disorders (including hyperprolactinemia & hyperthyroidism)
Onorach keep abreast of Regulatory guidance (e.g. emphasis on assessing cardiovascular risk for diabetes patients in the FDA’s focus on diabetes drug development) which has altered the clinical development landscape for anti-diabetic therapies. Onorach have strategies in place to deal with the implications of extensions to trial length, increasing costs of development and complexity of data requirements.
It is critical, now more than ever, to have a partner who understands the implications throughout the product lifecycle to:
  • Ensure trial development meets global regulations
  • Track cardiovascular events
  • Assess long term risk
  • Improve market access
Contact us for more information...

Client Testimonial

Prof. Leiper and her team at Onorach have demonstrated competencies in many areas in both working with the authorities and with the sites as monitors. They impressed us deeply with highly motivated, goal-oriented staff members of lively personality and creativity. It was always a pleasure to cooperate with Onorach Clinical.
A German Client